Science News

Friday, Apr 19, 2024 | Last Update : 12:20 PM IST

Science

Science Page-10

Health worker participating in the trial of Covaxin (Image source: PTI)

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity

One adverse event was reported but was unrelated to the vaccine

22 Jan 2021 4:13 PM

A medical worker shows a vial of Covishield vaccine as she prepares to inoculate a medical staff at Rajiv Gandhi Super Speciality Hospital, in New Delhi on January 19, 2021. (AFP)

Covishield not to be taken by those allergic to its ingredients: Serum Institute

A total of 580 adverse events were reported following immunisation for COVID-19 in the country till 5 pm on Monday

19 Jan 2021 3:28 PM

Humans have hunted Sulawesi warty pigs for tens of thousands of years, and they are a key feature of the region's prehistoric artwork, particularly during the Ice Age. (Photo:AFP)

World's oldest known cave painting found in Indonesia

The painting is a life-sized picture of a wild pig that was made at least 45,500 years ago

14 Jan 2021 1:00 AM

Despite vaccines, no Covid herd immunity in 2021: WHO

Chief scientist Soumya Swaminathan warned that it will take time to produce and administer enough doses to halt the spread of the virus

12 Jan 2021 12:32 AM

Aerosol sources include extensive burning of crop residue and forest fires, besides exhaust from vehicles, as also from other aspects of rapid urbanization and industrialisation. — Representational image/AP

Decreasing trend in black carbon Aerosol concentrations

Aerosols, the tiny particles suspended in the atmosphere, affect life through adverse health effects and have an enormous impact on climate

11 Jan 2021 11:45 PM

When the researchers tested the sera of 20 participants who received the Pfizer-BioNTech vaccine they found that it could act against the engineered coronavirus variants. (Photo:AFP)

Pfizer vaccine may protect against new mutations of coronavirus

Owing to the evolution of the coronavirus, scientists have called for the continuous monitoring of changes in the virus for vaccine coverage

09 Jan 2021 4:38 AM

The vaccine was tried on hamsters and monkeys and it was found that after administration of both doses, there were no virus particles in upper and lower lungs

Covaxin: Last word on efficacy yet to be heard

Doubts raised over clinical trial mode as to why vaccine given permission without completion of human trials

05 Jan 2021 4:01 AM

Bharat Biotech aims to recruit 26,000 volunteers across the country for the Phase-3 trials; it has crossed the 23,000-volunteer mark. (AFP)

Vaccine makers call approval a giant leap

SII has stockpiled around 5 crore dosages of the vaccine and aims to produce up to 10 crore per month by March next year

04 Jan 2021 11:22 AM

A medical staff member conducts a COVID-19 rapid test on a bicycle rider at a drive-through testing site. (Representational Image: AP)

New coronavirus strain may replace the old one, say experts

The biggest worry is the status of the vaccines due to the emerging new strains

25 Dec 2020 6:44 AM

Bharat Biotech has been asked to submit more details to the subject committee of the Central Drugs Standard Control Organisation for a review (AFP)

Bharat Biotech sends Phase-2 study results of Covaxin trial

Altogether, the data of human trials on 26,000 volunteers has to be submitted by the company to the subject committee

24 Dec 2020 4:39 AM

The major worry with the new UK variant is that it is 70 percent more transmissible than the existing strains.

Genome sequencing takes a hit in India

Problems aplenty in importing chemicals

22 Dec 2020 2:00 AM

With new variant strains, analysis of efficacy can be known only after a critical mass of the population is inoculated.

Experts call for molecular sequencing of the virus

Intensified vaccination programme most viable: Researchers

22 Dec 2020 2:00 AM

Last week, Pfizer India said it has applied to India's drug regulator DCGI for emergency-use authorisation for its COVID-19 vaccine. (Representational Image:AFP)

Serum Institute applies for emergency use authorisation for COVID-19 vaccine

The Pune-based company has collaborated with Oxford University and pharmaceutical company Astra Zeneca for making the vaccine

07 Dec 2020 11:49 AM

No severe safety event on Covid vaccine: AstraZeneca

There were 23,000 participants being assessed, who among them would be following two regimes of half dose and full dose

24 Nov 2020 2:05 AM

Oxford University COVID-19 vaccine 'encouraging' for older age groups

Older individuals are at disproportionate risk of severe COVID-19 and so any vaccine adopted for use must be effective in older adults

19 Nov 2020 2:38 PM

Explained |Here's how coronavirus vaccine trials work

To find out whether experimental Covid-19 vaccines are effective, researchers design clinical trials involving thousands of volunteers

19 Nov 2020 6:28 AM

US-backed Pfizer-BioNTech and Russia's Sputnik V need much lower storage temperature conditions compared to protein-based vaccine candidates like the one developed by Novavax. (Representational Image:AP)

Protein-based COVID vaccine candidates more suitable for India, scientists say

That potentially rules out the 3 vaccine candidates that have shown over 90% efficiency over the last week - Pfizer, Sputnik V and Moderna

18 Nov 2020 5:30 PM

Moderna says its COVID-19 vaccine candidate is 94.5% effective

Moderna's announcement comes just a week after Pfizer said their COVID-19 vaccine candidate was more than 90 per cent effective

17 Nov 2020 6:15 AM

Celestial excitement in store for sky gazers this month

Jupiter and Saturn will be shining bright in the southwestern hemisphere and Venus will shine right before dawn

13 Nov 2020 4:23 AM

Russia’s Sputnik V arrives, officials claim 92% effective

The interim research data of Sputnik V has not been published or peer-reviewed yet

12 Nov 2020 7:15 AM

10 of 107

Columns

Mohan Guruswamy